Agile Therapeutics, Inc. (AGRX)

0.6506 -0.0351 (-5.12%) At close: 04:00PM EST

Agile Therapeutics, Inc.

101 Poor Farm Road
Princeton, NJ 08540
United States
609 683 1880
http://www.agiletherapeutics.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 28

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Alfred F. Altomari	Chairman & CEO	894.05k	N/A	1959
Mr. Dennis P. Reilly	Sr. VP & CFO	550.76k	N/A	1959
Mr. Geoffrey P. Gilmore	Sr. VP, Gen. Counsel & Corp. Sec.	701.53k	N/A	1966
Jason Butch	VP & Chief Accounting Officer	N/A	N/A	N/A
Ms. Tristen Herrstrom	Sr. VP of HR & Admin.	N/A	N/A	N/A
Matthew Riley	Head of Investor Relations & Corp. Communications	N/A	N/A	N/A
Ms. Amy Welsh	VP of Marketing	N/A	N/A	N/A
Mr. Robert G. Conway	Sr. VP & Chief Supply Chain Officer	N/A	N/A	1957
Dr. Elizabeth Ijeoma Onyemelukwe Garner M.D., M.P.H.	Consultant	N/A	N/A	1968
Dr. Paul Korner	Sr. VP & Chief Medical Officer	N/A	N/A	1966

Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other transdermal contraceptive products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and AG890, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.

Corporate Governance

Agile Therapeutics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.